To obtain a pharmaceutical composition for treating inflammatory disorders in a human, comprising a resorcinol derivative.

This pharmaceutical composition for treating inflammatory disorders and for topical administration or dermal administration comprises a compound of formula (I) (such as 4-cyclohexylresorcinol) or its pharmaceutically acceptable salt and a pharmaceutically acceptable carrier. In formula (1), X is H; OR1 [R1 is H, a 1-6C alkyl or an aryl-(1-6C) alkyl], OCOR2 [R2 is a 1-6C alkyl, an aryl-(1-6C) alkyl or phenyl], a halogen, a 1-6C alkyl, an aryl-(1-6C) alkyl, SR3 [R3 is H, a 1-6C alkyl, or an aryl-(1-6C) alkyl], or NHR1 (R1 is defined as above); (n) is 0-3; and the straight line with the dashed line represents an optionally existing double bond.